CAMPBELL, Calif., Sept. 11, 2019 /PRNewswire/ -- Atia Vision, Inc., a Shifamed portfolio company committed to improving patient outcomes through the development of a novel modular presbyopia-correcting intraocular lens (IOL), today announced its technology will be featured in presentations at two ophthalmology conferences this week in Paris

PRINCETON, N.J., Sept. 11, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has appointed Jonathan Guarino, as its Senior Vice Pres

BOCA RATON, Fla., Sept. 11, 2019 /PRNewswire/ -- Arcline Investment Management ("Arcline"), a growth oriented private equity firm with $1.5 billion of capital under management, today announced that it has acquired a majority interest in Akron Biotechnology LLC ("Akron" or "The Company"). Akron will continue to be led by Claudia Zylberberg

AMSTERDAM, Sept. 11, 2019 /PRNewswire/ -- At the 4th Annual European Forum on Nanoscale IR Spectroscopy, Bruker (Nasdaq: BRKR) today announced the release of the nanoIR3-s Broadband™, the most advanced nanoscale FTIR spectroscopy system available to researchers. The system combines Bruker's industry-leading, high-performance, nanoIR3-s

LOS ANGELES, Sept. 11, 2019 /PRNewswire/ -- O&O Academy today announced it will hold its 2nd annual 

REHOVOT, Israel, Sept. 11, 2019 /PRNewswire/ -- Lavie Bio, a subsidiary of Evogene (NASDAQ: EVGN) (TASE: EVGN), focusing on improving food quality, agricultural sustainability and productivity through the development of novel microbiome based agriculture biological products, today announced the nomination of several notable industry ex

TAIZHOU, China, Sept. 11, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and 

SAN DIEGO, Sept. 11, 2019 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, announced that Andreas Muehler, M.D., Chief Medical Officer of Immunic, will pr

JUPITER, Fla., Sept. 11, 2019 /PRNewswire/ -- Excel Medical, an innovator in modernizing cardiac telemetry and medical device integration (MDI), today announced it entered into a collabor

PHOENIX, Sept. 11, 2019 /PRNewswire/ -- University of Phoenix today announced findings from their third annual first responders' survey regarding perceptions about mental health. The online survey conducted by The Harris Poll on behalf of the University finds that first responders continue to believe mental health is as important as